Sirohi P, Kumari A, Admane N, Somvanshi P, Grover A
RSC Adv. 2022; 11(42):25901-25911.
PMID: 35479435
PMC: 9037109.
DOI: 10.1039/d1ra01891d.
Hwang S, Greenlee J, Nicholson E
Front Vet Sci. 2021; 8:643754.
PMID: 33748218
PMC: 7969510.
DOI: 10.3389/fvets.2021.643754.
Ortega M, Guzman Merino A, Fraile-Martinez O, Recio-Ruiz J, Pekarek L, Guijarro L
Pharmaceutics. 2020; 12(9).
PMID: 32937793
PMC: 7560085.
DOI: 10.3390/pharmaceutics12090874.
Hwang S, Greenlee J, Nicholson E
PLoS One. 2020; 15(1):e0227487.
PMID: 31910440
PMC: 6946595.
DOI: 10.1371/journal.pone.0227487.
Hwang S, Dassanayake R, Nicholson E
BMC Res Notes. 2019; 12(1):806.
PMID: 31836019
PMC: 6911270.
DOI: 10.1186/s13104-019-4842-7.
Thermostability as a highly dependent prion strain feature.
Marin-Moreno A, Aguilar-Calvo P, Moudjou M, Espinosa J, Beringue V, Torres J
Sci Rep. 2019; 9(1):11396.
PMID: 31388046
PMC: 6684573.
DOI: 10.1038/s41598-019-47781-6.
Source genotype influence on cross species transmission of transmissible spongiform encephalopathies evaluated by RT-QuIC.
Hwang S, Greenlee J, Vance N, Nicholson E
PLoS One. 2018; 13(12):e0209106.
PMID: 30571737
PMC: 6301698.
DOI: 10.1371/journal.pone.0209106.
Thermodynamic characterization for the denatured state of bovine prion protein and the BSE Associated variant E211K.
Hwang S, Nicholson E
Prion. 2018; 12(5-6):301-309.
PMID: 30354921
PMC: 6277186.
DOI: 10.1080/19336896.2018.1534485.
Use of bovine recombinant prion protein and real-time quaking-induced conversion to detect cattle transmissible mink encephalopathy prions and discriminate classical and atypical L- and H-Type bovine spongiform encephalopathy.
Hwang S, Greenlee J, Nicholson E
PLoS One. 2017; 12(2):e0172391.
PMID: 28225797
PMC: 5321280.
DOI: 10.1371/journal.pone.0172391.
C and N chemical shift assignments of mammalian Y145Stop prion protein amyloid fibrils.
Theint T, Nadaud P, Surewicz K, Surewicz W, Jaroniec C
Biomol NMR Assign. 2016; 11(1):75-80.
PMID: 28004358
PMC: 5344711.
DOI: 10.1007/s12104-016-9723-6.
Potential approaches for heterologous prion protein treatment of prion diseases.
Seelig D, Goodman P, Skinner P
Prion. 2015; 10(1):18-24.
PMID: 26636482
PMC: 4981202.
DOI: 10.1080/19336896.2015.1123372.
Examining the Neural and Astroglial Protective Effects of Cellular Prion Protein Expression and Cell Death Protease Inhibition in Mouse Cerebrocortical Mixed Cultures.
Wang K, Yang Z, Chiu A, Lin F, Rubenstein R
Mol Neurobiol. 2015; 53(7):4821-32.
PMID: 26337296
PMC: 4955631.
DOI: 10.1007/s12035-015-9407-8.
Treatment of Prion Disease with Heterologous Prion Proteins.
Skinner P, Kim H, Bryant D, Kinzel N, Reilly C, Priola S
PLoS One. 2015; 10(7):e0131993.
PMID: 26134409
PMC: 4489745.
DOI: 10.1371/journal.pone.0131993.
Molecular dynamics simulation of temperature induced unfolding of animal prion protein.
Chen X, Duan D, Zhu S, Zhang J
J Mol Model. 2013; 19(10):4433-41.
PMID: 23925513
DOI: 10.1007/s00894-013-1955-0.
Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy.
Helmus J, Surewicz K, Apostol M, Surewicz W, Jaroniec C
J Am Chem Soc. 2011; 133(35):13934-7.
PMID: 21827207
PMC: 3164902.
DOI: 10.1021/ja206469q.
Neuroprotective effects of the cellular prion protein in autoimmune optic neuritis.
Williams S, Fairless R, Weise J, Kalinke U, Schulz-Schaeffer W, Diem R
Am J Pathol. 2011; 178(6):2823-31.
PMID: 21641403
PMC: 3124096.
DOI: 10.1016/j.ajpath.2011.02.046.
Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
Afanasieva E, Kushnirov V, Tuite M, Ter-Avanesyan M
J Biol Chem. 2011; 286(18):15773-80.
PMID: 21454674
PMC: 3091186.
DOI: 10.1074/jbc.M110.183889.
Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy.
Helmus J, Surewicz K, Surewicz W, Jaroniec C
J Am Chem Soc. 2010; 132(7):2393-403.
PMID: 20121096
PMC: 2838504.
DOI: 10.1021/ja909827v.
Prion diseases and their biochemical mechanisms.
Cobb N, Surewicz W
Biochemistry. 2009; 48(12):2574-85.
PMID: 19239250
PMC: 2805067.
DOI: 10.1021/bi900108v.
Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
Cobb N, Apetri A, Surewicz W
J Biol Chem. 2008; 283(50):34704-11.
PMID: 18930924
PMC: 2596397.
DOI: 10.1074/jbc.M806701200.
